Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Talking To Tunis: Former CMS Medical Chief Works To Improve Tech Studies

This article was originally published in The Gray Sheet

Executive Summary

A major barrier to making the U.S. health care system more cost effective is the dearth of good effectiveness data on many expensive therapies, says former CMS Chief Medical Officer Sean Tunis

You may also be interested in...



Advancing Comparative Effectiveness Research: An Interview with Sean Tunis

Sean Tunis is director of the Center for Medical Technology Policy and a leading advocate for comparative effectiveness research and evidence-based medicine. Formerly Director of the Office of Clinical Standards and Quality and CMO of the Centers for Medicare & Medicaid Services, he discusses the state of comparative effectiveness advocacy and his current work developing medical device protocols aimed at providing actionable information to physicians, patients, and payors.

Advancing Comparative Effectiveness Research: An Interview with Sean Tunis

Sean Tunis is director of the Center for Medical Technology Policy and a leading advocate for comparative effectiveness research and evidence-based medicine. Formerly Director of the Office of Clinical Standards and Quality and CMO of the Centers for Medicare & Medicaid Services, he discusses the state of comparative effectiveness advocacy and his current work developing medical device protocols aimed at providing actionable information to physicians, patients, and payors.

Evidence-Based Medicine Only Goes So Far, Policy Experts Argue

Evidence-based medicine will not relieve patients, doctors and health care policy makers of their duty to make difficult judgments about values and cost-effectiveness, two experts contend.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT024980

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel